The third snapshot in the Covid-19 CGAP-Symbiotics series is availableWednesday 28th, April 2021
This latest update confirms that the microfinance sector remains resilient and on its way to a cautious and gradual recovery, but the pace depends on type of institution, region, and capital buffers.
Read the latest snapshot with a spotlight on Latin America: Snapshot: MFIs During the Crisis – Ap
Returning to microfinance field visits in IndiaWednesday 24th, February 2021
Shefali’s travel notes, Investment Analyst in Singapore
When I arrived in India a couple weeks ago, after many months confined in Singapore, the most bizarre thing of all that struck me was how normal things appeared. At least superficially. The usual hustle and bustle on the streets has resumed
The second snapshot in the Covid-19 CGAP-Symbiotics series is availableTuesday 23rd, February 2021
This update confirms that MFIs remain resilient. A year into the COVID-19 pandemic, liquidity concerns in the microfinance sector have not materialized as anticipated. Where loan payments moratoria ended, repayments rates have been encouraging. Disbursements are also picking up again, closer to what
CGAP and Symbiotics partner to monitor COVID-19’s impact on MicrofinanceTuesday 17th, November 2020
CGAP and Symbiotics launched a partnership to track and analyze the performance of hundreds of microfinance institutions (MFIs) across the world over the next six months, in an ongoing effort to shed light on how the COVID-19 pandemic is impacting the microfinance sector.
The COVID-19 pandemic ha
Symbiotics statement on the Coronavirus (COVID-19) epidemicThursday 19th, March 2020
Geneva, March 18, 2020
Dear Clients and Partners,
We would like to update you on Symbiotics’ response to the pandemic situation and public health policies being put in place in our various markets and locations.
Our priority is to reduce the risk of infection of our clients, partners and